June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Baicalein lowers intraocular pressure and increases outflow facility in mouse eye
Author Affiliations & Notes
  • Hoi Lam Li
    School of Optometry, The Hong Kong Polytechnic University, Hong Kong, Hong Kong
  • Nicole E. Ashpole
    Department of Ophthalmology, Duke University School of Medicine, Durham, NC
  • Iris D Navarro
    Department of Ophthalmology, Duke University School of Medicine, Durham, NC
  • Thomas C Lam
    School of Optometry, The Hong Kong Polytechnic University, Hong Kong, Hong Kong
  • Ho Lung Henry Chan
    School of Optometry, The Hong Kong Polytechnic University, Hong Kong, Hong Kong
  • Chi Ho To
    School of Optometry, The Hong Kong Polytechnic University, Hong Kong, Hong Kong
  • W Daniel Stamer
    Department of Ophthalmology, Duke University School of Medicine, Durham, NC
  • Chi-wai Do
    School of Optometry, The Hong Kong Polytechnic University, Hong Kong, Hong Kong
  • Footnotes
    Commercial Relationships Hoi Lam Li, None; Nicole Ashpole, None; Iris Navarro, None; Thomas C Lam, None; Ho Lung Henry Chan, None; Chi Ho To, None; W Stamer, None; Chi-wai Do, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4853. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hoi Lam Li, Nicole E. Ashpole, Iris D Navarro, Thomas C Lam, Ho Lung Henry Chan, Chi Ho To, W Daniel Stamer, Chi-wai Do; Baicalein lowers intraocular pressure and increases outflow facility in mouse eye. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4853. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Baicalein is a natural flavonoid derived from the root of Scutellaria baicalensis. We have previously demonstrated that intraperitoneal administration of baicalein lowers intraocular pressure (IOP) in rodents. In this study, we aimed to investigate whether 1) similar ocular hypotensive effects were observed after topical application rather than intraperitoneal injection; and 2) baicalein altered the outflow facility using freshly enucleated mouse eyes.

Methods: Adult C57BL/6J (B6) mice were used. Intraocular pressure (IOP) was measured by rebound tonometry under awake condition. Topical baicalein (20 µL, 10 mM) was applied to the treatment eye twice separated by 10-min intervals while phosphate buffered saline (PBS) was used in the fellow eye as control. IOP measurements were conducted before and after drug administration (i.e. 1.5, 3, 6, 24, 48 and 72 h) in both light and dark phases. The outflow facility was determined by measuring the flow rates at sequential pressure steps (i.e. 4, 8, 12, 16 and 20 mmHg) in freshly enucleated mice eyes. Comparisons were made between the baicalein-treated and vehicle-treated contralateral eye of the same animal.

Results: Topical administration of 10 mM baicalein caused significant IOP reduction within 6 hours after drug treatment. The maximum IOP-lowering effect was 1.44±0.25 (n = 23, p < 0.01) and 2.16±0.37 (n = 23, p < 0.01) mmHg under light and dark conditions, respectively. In addition, 10µM baicalein significantly enhanced the outflow facility in paired mouse eyes (n = 4, p < 0.05). The outflow facility of baicalein-treated and control eyes were 0.041±0.010 and 0.021±0.005 µL/min/mmHg, respectively.

Conclusions: Topical application of baicalein triggered a transient IOP reduction although its effect was smaller than that of intraperitoneal injection. The ocular hypotensive effect was mediated, at least in part, by the facilitation of aqueous outflow. The precise mechanism of action remains to be determined.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×